2022
DOI: 10.1055/a-1872-0546
|View full text |Cite
|
Sign up to set email alerts
|

Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer Correlates with Worse Prognosis and Cancer Progression

Abstract: Given the characters of “Silent killer”, epithelial ovarian cancer (EOC) usually suffered late diagnosis and poor prognosis. Therefore, this study aimed to explore the prognostic significance of ASMTL-AS1 in EOC and investigated the effect of lncRNA ASMTL-AS1 dysregulation on tumor cellular function. ASMTL-AS1 expression was analyzed in 133 EOC tissues and five kinds of cell lines by RT-qPCR. The expression of A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…The 5-year survival rate of EOC patients is not satisfied. To elucidate the mechanisms underlying EOC metastasis and improve the clinical prognosis, efforts have been made to investigate ncRNA features of EOC [26,27]. However, these ncRNA signatures have not been well implemented clinically.…”
Section: Discussionmentioning
confidence: 99%
“…The 5-year survival rate of EOC patients is not satisfied. To elucidate the mechanisms underlying EOC metastasis and improve the clinical prognosis, efforts have been made to investigate ncRNA features of EOC [26,27]. However, these ncRNA signatures have not been well implemented clinically.…”
Section: Discussionmentioning
confidence: 99%
“…[ 7 ] ASMTL‐AS1 strongly decreases cell proliferation, migration, and invasion in epithelial ovarian cancer. [ 8 ] Exosomal ASMTL‐AS1 aggravates the malignancy of residual hepatocellular carcinoma. [ 9 ] However, whether ASMTL‐AS1 affects RCC progression has not been investigated.…”
Section: Introductionmentioning
confidence: 99%